ARDT

insider transactions

Ardent Health, Inc. — buys & sells by directors, officers and 10% owners (SEC Form 4).

30D 90D 1Y

No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.

Net buy / sell volume

Tap or hover the chart for daily net volume. Green = net buying, red = net selling.

All transactions

Grant·A
Apr 1, 26

Bulgarelli Peter J.

Director

$0

14.2K sh

Own New
Grant·A
Apr 1, 26

Havdala Ellen

Director

$0

14.2K sh

Own +14%
Grant·A
Apr 1, 26

Sotir Mark R

Director

$0

14.2K sh

Own +58%
Grant·A
Apr 1, 26

Sen Rahul

Director

$0

14.2K sh

Own +58%
Grant·A
Apr 1, 26

Webb Robert Thomas

Director

$0

14.2K sh

Own +22%
Grant·A
Apr 1, 26

Robinson Edmondo

Director

$0

14.2K sh

Own +32%
Grant·A
Apr 1, 26

DeMichiei Robert

Director

$0

14.2K sh

Own +141%
Grant·A
Apr 1, 26

GOODYEAR WILLIAM M

Director

$0

14.2K sh

Own +14%
Grant·A
Apr 1, 26

Campion Suzanne

Director

$0

14.2K sh

Own +32%
Grant·A
Apr 1, 26

BYNOE PETER C B

Director

$0

14.2K sh

Own +14%
Grant·A
Apr 1, 26

Caspers Dave

Chief Operating Officer

$0

35.7K sh

Own +100%
Other·F
Apr 1, 26

Caspers Dave

Chief Operating Officer

$23.3K

2.7K sh · $8.67

Own -7%
Grant·A
Apr 1, 26

Petrovich Stephen C.

EVP, GC and Secretary

$0

24.9K sh

Own +3%
Other·F
Apr 1, 26

Petrovich Stephen C.

EVP, GC and Secretary

$15.7K

1.8K sh · $8.67

Own -0%
Grant·A
Apr 1, 26

Byers David Raynor

SVP & Chief Accounting Officer

$0

11.5K sh

Own +10%
Other·F
Apr 1, 26

Byers David Raynor

SVP & Chief Accounting Officer

$8.0K

924 sh · $8.67

Own -1%
Grant·A
Apr 1, 26

LUMSDAINE ALFRED KEY

Chief Financial Officer

$0

53.8K sh

Own +20%
Other·F
Apr 1, 26

LUMSDAINE ALFRED KEY

Chief Financial Officer

$38.0K

4.4K sh · $8.67

Own -2%
Grant·A
Apr 1, 26

Bonick Martin KEY

President and CEO

$0

134.6K sh

Own +10%
Other·F
Apr 1, 26

Bonick Martin KEY

President and CEO

$95.0K

11.0K sh · $8.67

Own -1%
Other·F
Mar 31, 26

Petrovich Stephen C.

EVP, GC and Secretary

$12.2K

1.4K sh · $8.56

Own -0%
Other·F
Mar 31, 26

Byers David Raynor

SVP & Chief Accounting Officer

$7.0K

819 sh · $8.56

Own -1%
Other·F
Mar 31, 26

LUMSDAINE ALFRED KEY

Chief Financial Officer

$21.5K

2.5K sh · $8.56

Own -1%
Other·F
Mar 31, 26

Bonick Martin KEY

President and CEO

$68.7K

8.0K sh · $8.56

Own -1%
Grant·A
Mar 11, 26

LUMSDAINE ALFRED KEY

Chief Financial Officer

$0

61.1K sh

Own +29%
Grant·A
Mar 11, 26

Bonick Martin KEY

President and CEO

$0

195.3K sh

Own +17%
Grant·A
Mar 11, 26

Chernin Ethan KEY

President of Health Services

$0

32.4K sh

Own +90%
Grant·A
Mar 11, 26

Byers David Raynor

SVP & Chief Accounting Officer

$0

8.9K sh

Own +8%
Grant·A
Mar 11, 26

Petrovich Stephen C.

EVP, GC and Secretary

$0

34.7K sh

Own +5%
Other·F
Sep 25, 25

Byers David Raynor

SVP & Chief Accounting Officer

$6.9K

524 sh · $13.19

Own -0%
Other·F
Sep 25, 25

Petrovich Stephen C.

EVP, GC and Asst. Secretary

$10.4K

788 sh · $13.19

Own -0%
Other·F
Sep 25, 25

LUMSDAINE ALFRED KEY

Chief Financial Officer

$44.7K

3.4K sh · $13.19

Own -2%

Date▾	Insider	Role	Type	Shares	Own Δ	Price	Value
Apr 1, 2026	Bulgarelli Peter J.	Director	Grant A	14.2K	New	—	$0
Apr 1, 2026	Havdala Ellen	Director	Grant A	14.2K	+14%	—	$0
Apr 1, 2026	Sotir Mark R	Director	Grant A	14.2K	+58%	—	$0
Apr 1, 2026	Sen Rahul	Director	Grant A	14.2K	+58%	—	$0
Apr 1, 2026	Webb Robert Thomas	Director	Grant A	14.2K	+22%	—	$0
Apr 1, 2026	Robinson Edmondo	Director	Grant A	14.2K	+32%	—	$0
Apr 1, 2026	DeMichiei Robert	Director	Grant A	14.2K	+141%	—	$0
Apr 1, 2026	GOODYEAR WILLIAM M	Director	Grant A	14.2K	+14%	—	$0
Apr 1, 2026	Campion Suzanne	Director	Grant A	14.2K	+32%	—	$0
Apr 1, 2026	BYNOE PETER C B	Director	Grant A	14.2K	+14%	—	$0
Apr 1, 2026	Caspers Dave	Chief Operating Officer	Grant A	35.7K	+100%	—	$0
Apr 1, 2026	Caspers Dave	Chief Operating Officer	Other F	2.7K	-7%	$8.67	$23.3K
Apr 1, 2026	Petrovich Stephen C.	EVP, GC and Secretary	Grant A	24.9K	+3%	—	$0
Apr 1, 2026	Petrovich Stephen C.	EVP, GC and Secretary	Other F	1.8K	-0%	$8.67	$15.7K
Apr 1, 2026	Byers David Raynor	SVP & Chief Accounting Officer	Grant A	11.5K	+10%	—	$0
Apr 1, 2026	Byers David Raynor	SVP & Chief Accounting Officer	Other F	924	-1%	$8.67	$8.0K
Apr 1, 2026	LUMSDAINE ALFRED KEY	Chief Financial Officer	Grant A	53.8K	+20%	—	$0
Apr 1, 2026	LUMSDAINE ALFRED KEY	Chief Financial Officer	Other F	4.4K	-2%	$8.67	$38.0K
Apr 1, 2026	Bonick Martin KEY	President and CEO	Grant A	134.6K	+10%	—	$0
Apr 1, 2026	Bonick Martin KEY	President and CEO	Other F	11.0K	-1%	$8.67	$95.0K
Mar 31, 2026	Petrovich Stephen C.	EVP, GC and Secretary	Other F	1.4K	-0%	$8.56	$12.2K
Mar 31, 2026	Byers David Raynor	SVP & Chief Accounting Officer	Other F	819	-1%	$8.56	$7.0K
Mar 31, 2026	LUMSDAINE ALFRED KEY	Chief Financial Officer	Other F	2.5K	-1%	$8.56	$21.5K
Mar 31, 2026	Bonick Martin KEY	President and CEO	Other F	8.0K	-1%	$8.56	$68.7K
Mar 11, 2026	LUMSDAINE ALFRED KEY	Chief Financial Officer	Grant A	61.1K	+29%	—	$0
Mar 11, 2026	Bonick Martin KEY	President and CEO	Grant A	195.3K	+17%	—	$0
Mar 11, 2026	Chernin Ethan KEY	President of Health Services	Grant A	32.4K	+90%	—	$0
Mar 11, 2026	Byers David Raynor	SVP & Chief Accounting Officer	Grant A	8.9K	+8%	—	$0
Mar 11, 2026	Petrovich Stephen C.	EVP, GC and Secretary	Grant A	34.7K	+5%	—	$0
Sep 25, 2025	Byers David Raynor	SVP & Chief Accounting Officer	Other F	524	-0%	$13.19	$6.9K
Sep 25, 2025	Petrovich Stephen C.	EVP, GC and Asst. Secretary	Other F	788	-0%	$13.19	$10.4K
Sep 25, 2025	LUMSDAINE ALFRED KEY	Chief Financial Officer	Other F	3.4K	-2%	$13.19	$44.7K

About ARDT insider trading

This page tracks insider transactions for Ardent Health, Inc. (ARDT) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.